Dong, L., Lou, W., Xu, C., & Wang, J. Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota. BMC.
Chicago Style (17th ed.) CitationDong, Lu, Wenyong Lou, Congfei Xu, and Juan Wang. Naringenin Cationic Lipid-modified Nanoparticles Mitigate MASLD Progression by Modulating Lipid Homeostasis and Gut Microbiota. BMC.
MLA (9th ed.) CitationDong, Lu, et al. Naringenin Cationic Lipid-modified Nanoparticles Mitigate MASLD Progression by Modulating Lipid Homeostasis and Gut Microbiota. BMC.
Warning: These citations may not always be 100% accurate.